Circular Genomics
Developing advanced genomic sequencing technologies for personalized medicine and research.
About
Circular Genomics is revolutionizing neurological and psychiatric care with its circular RNA platform, aiming to make brain disorders measurable and manageable. Their first product, MindLightâ„¢, is a circular RNA-based diagnostic test that predicts SSRI response in depression patients, and they are developing blood-based assays for other neurological conditions like Alzheimer's disease. The company provides actionable brain biomarker data to clinicians and payers to inform personalized treatment decisions. Teams look it up for Genomics, Biotech, HealthTech.
Frequently asked
What does Circular Genomics do?
Circular Genomics is a Genomics company that offers Technology. Teams look it up for Biotech, HealthTech, DNA Data Storage. It is based in Jerusalem, Israel and was founded in 2017. Public records show about 18 people and $20M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Circular Genomics raised?
Circular Genomics has raised a total of $20M in funding. The most recent round on record is Series A.
Where is Circular Genomics headquartered?
Circular Genomics is headquartered in Jerusalem, Israel.
When was Circular Genomics founded?
Circular Genomics was founded in 2017.
What industry does Circular Genomics operate in?
Circular Genomics operates in Genomics, Biotech, HealthTech, DNA Data Storage, Sequencing Technology.
How many employees does Circular Genomics have?
Circular Genomics has approximately 18 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.